No abstract available
Keywords:
HIV; absoprtion; dolutegravir; intensive carer; pharmacokinetics.
MeSH terms
-
Anti-HIV Agents* / therapeutic use
-
Critical Illness
-
HIV Infections* / drug therapy
-
Heterocyclic Compounds, 3-Ring / therapeutic use
-
Humans
-
Oxazines / therapeutic use
-
Piperazines
-
Pyridones / therapeutic use
Substances
-
Anti-HIV Agents
-
Heterocyclic Compounds, 3-Ring
-
Oxazines
-
Piperazines
-
Pyridones
-
dolutegravir